Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandra Alessi

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Tumori|September 10, 2015
FDG-PET/CT to predict optimal primary cytoreductive surgery in patients with advanced ovarian cancer: preliminary resultsAlessandra Alessi, Fabio Martinelli, Barbara Padovano, et al.
European Journal of Cancer (Oxford, England : 1990)|July 10, 2022
Exceptional tumour responses to fasting-mimicking diet combined with standard anticancer therapies: A sub-analysis of the NCT03340935 trialFrancesca Ligorio, Giovanni Fucà, Leonardo Provenzano, et al.
Cancer|November 17, 2022
Combination of Deauville score and quantitative positron emission tomography parameters as a predictive tool of anti-CD19 chimeric antigen receptor T-cell efficacyAnna Guidetti, Anna Dodero, Alice Lorenzoni, et al.
La Radiologia Medica|December 19, 2018
Role of pretreatment 18F-FDG PET/CT parameters in predicting outcome of non-endemic EBV DNA-related nasopharyngeal cancer (NPC) patients treated with IMRT and chemotherapyAlessandra Alessi, Alice Lorenzoni, Anna Cavallo, et al.
Oncology|January 19, 2013
Is the standardized uptake value of FDG-PET/CT predictive of pathological complete response in locally advanced rectal cancer treated with capecitabine-based neoadjuvant chemoradiation?Chiara Bampo, Alessandra Alessi, Simona Fantini, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 13, 2015
¹⁸F-FLT PET/CT as an imaging tool for early prediction of pathological response in patients with locally advanced breast cancer treated with neoadjuvant chemotherapy: a pilot studyFlavio Crippa, Roberto Agresti, Marco Sandri, et al.
Breast (Edinburgh, Scotland)|February 4, 2014
Different biological and prognostic breast cancer populations identified by FDG-PET in sentinel node-positive patients: results and clinical implications after eight-years follow-upRoberto Agresti, Flavio Crippa, Marco Sandri, et al.
European Journal of Hybrid Imaging|June 30, 2021
Methodological framework for radiomics applications in Hodgkin's lymphomaMartina Sollini, Margarita Kirienko, Lara Cavinato, et al.
Cancer Discovery|June 22, 2016
MET-Driven Resistance to Dual EGFR and BRAF Blockade May Be Overcome by Switching from EGFR to MET Inhibition in BRAF-Mutated Colorectal CancerFilippo Pietrantonio, Daniele Oddo, Annunziata Gloghini, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 21, 2025
Radioembolization of hepatocellular carcinoma with <sup>90</sup>Y glass microspheres: an earlier administration day unexpectedly improves tumour control probabilityMatteo Bagnalasta, Stefania Mazzaglia, Maria Chiara De Nile, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Tumori|September 10, 2015
FDG-PET/CT to predict optimal primary cytoreductive surgery in patients with advanced ovarian cancer: preliminary resultsAlessandra Alessi, Fabio Martinelli, Barbara Padovano, et al.
European Journal of Cancer (Oxford, England : 1990)|July 10, 2022
Exceptional tumour responses to fasting-mimicking diet combined with standard anticancer therapies: A sub-analysis of the NCT03340935 trialFrancesca Ligorio, Giovanni Fucà, Leonardo Provenzano, et al.
Cancer|November 17, 2022
Combination of Deauville score and quantitative positron emission tomography parameters as a predictive tool of anti-CD19 chimeric antigen receptor T-cell efficacyAnna Guidetti, Anna Dodero, Alice Lorenzoni, et al.
La Radiologia Medica|December 19, 2018
Role of pretreatment 18F-FDG PET/CT parameters in predicting outcome of non-endemic EBV DNA-related nasopharyngeal cancer (NPC) patients treated with IMRT and chemotherapyAlessandra Alessi, Alice Lorenzoni, Anna Cavallo, et al.
Oncology|January 19, 2013
Is the standardized uptake value of FDG-PET/CT predictive of pathological complete response in locally advanced rectal cancer treated with capecitabine-based neoadjuvant chemoradiation?Chiara Bampo, Alessandra Alessi, Simona Fantini, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 13, 2015
¹⁸F-FLT PET/CT as an imaging tool for early prediction of pathological response in patients with locally advanced breast cancer treated with neoadjuvant chemotherapy: a pilot studyFlavio Crippa, Roberto Agresti, Marco Sandri, et al.
Breast (Edinburgh, Scotland)|February 4, 2014
Different biological and prognostic breast cancer populations identified by FDG-PET in sentinel node-positive patients: results and clinical implications after eight-years follow-upRoberto Agresti, Flavio Crippa, Marco Sandri, et al.
European Journal of Hybrid Imaging|June 30, 2021
Methodological framework for radiomics applications in Hodgkin's lymphomaMartina Sollini, Margarita Kirienko, Lara Cavinato, et al.
Cancer Discovery|June 22, 2016
MET-Driven Resistance to Dual EGFR and BRAF Blockade May Be Overcome by Switching from EGFR to MET Inhibition in BRAF-Mutated Colorectal CancerFilippo Pietrantonio, Daniele Oddo, Annunziata Gloghini, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 21, 2025
Radioembolization of hepatocellular carcinoma with <sup>90</sup>Y glass microspheres: an earlier administration day unexpectedly improves tumour control probabilityMatteo Bagnalasta, Stefania Mazzaglia, Maria Chiara De Nile, et al.
Pageof 3